Labshake search
Citations for Lonza :
1 - 50 of 763 citations for Recombinant HBV X Protein since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2023Quote: ... sgRNA and recombinant CAS9 were delivered as ribonucleoprotein (RNP) complexes using a 4D-Nucleofector X-Unit (Lonza). Briefly ...
-
bioRxiv - Bioengineering 2024Quote: ... and recombinant human insulin 0.5%) (Lonza). Human cervical cancer cell line SiHa from ATCC (ATCC® HTB-35™ ...
-
bioRxiv - Biochemistry 2023Quote: ... Sf21 cells seeded at 500,000 cells/mL were transfected with recombinant bacmid DNA to generate the initial baculovirus (P1) in Insect-XPRESSTM Protein-free Insect Cell Medium (Lonza). The P1 virus was amplified two times (P2 and P3 ...
-
bioRxiv - Cancer Biology 2020Quote: ... consisting of 100 pmol of chemically modified sgRNA (Synthego) and 35 pmol of Cas9 protein (St. Jude Protein Production Core) via nucleofection (Lonza, 4D-Nucleofector™ X-unit) using solution P3 and program CA-137 in small cuvettes according to the manufacturers recommended protocol ...
-
bioRxiv - Cell Biology 2023Quote: ... X-Vivo 15 medium: X-Vivo 15 (Lonza) supplemented with 1% Glutamax ...
-
bioRxiv - Cell Biology 2023Quote: ... 1.5-2.0 x 105 cells were electroporated with 200 pmol of protein in 20 µl cuvettes using a 4D nucleofector device (Lonza) according to the manufacturer’s recommendations ...
-
bioRxiv - Cancer Biology 2020Quote: ... recombinant Cas9 nuclease (IDT) and the 4D-Nucleofector (Lonza) as previously described (Wagenblast et al. ...
-
bioRxiv - Cancer Biology 2022Quote: ... human recombinant insulin (20 μg/mL, Lonza, #BE03-033E20), human recombinant EGF (2 ng/mL ...
-
bioRxiv - Molecular Biology 2020Quote: ... 1 x 106 MLN cells were cultured in X-vivo 15 medium (Lonza) supplemented with 1% L-glutamine (Invitrogen) ...
-
bioRxiv - Immunology 2019Quote: ... X-VIVO 15 media (Lonza) was used without additional serum ...
-
bioRxiv - Cell Biology 2023Quote: ... in X-VIVOTM 10 (Lonza) supplemented with 1% HSA (Baxter ...
-
bioRxiv - Neuroscience 2024Quote: ... and the X unit (Lonza) (program CA-137) ...
-
bioRxiv - Immunology 2024Quote: ... in X-vivo-15 (Lonza), supplemented with 1% L-glutamine (Gibco ...
-
bioRxiv - Immunology 2023Quote: ... were incubated with sgRNA and CAS9 protein complex and electroporation was done using P3 Primary Cell 4D-NucleofectorTM X Kit L (Lonza, cat # V4XP-3024) and Lonza 4D nucleofector system ...
-
bioRxiv - Immunology 2020Quote: ... 1.3×10^5 C25cl48 cells/reaction were electroporated with a ribonucleoprotein consisting of 125 pmol TrueCut Cas9 Protein v2 (A36498) + 150 pmol gRNA + 120 pmol ssDNA using P5 Primary Cell 4D-Nucleofector X Kit S (Lonza, Walkersville, MD, V4XP-5032) in a 16-well Nucleocuvette Strip and the Amaxa 4D-Nucleofector X Unit (Lonza ...
-
bioRxiv - Immunology 2019Quote: ... in X-Vivo 15 medium (Lonza), supplemented with 2% heat-inactivated FCS (Biochrom) ...
-
bioRxiv - Immunology 2021Quote: ... in X-vivo 15 medium (Lonza) supplemented with 5% human serum (Sigma ...
-
bioRxiv - Immunology 2021Quote: ... in X-Vivo 15 medium (Lonza), containing 5 % fetal calf serum (FCS ...
-
bioRxiv - Immunology 2022Quote: ... X-VIVO15 serum-free media (Lonza) was used to avoid T cell activity to bovine serum proteins ...
-
bioRxiv - Cancer Biology 2022Quote: ... in X-VIVO 15 medium (Lonza). Cells were activated and expanded for 48 hours followed by transduction 2 hours later with lentivirus ...
-
bioRxiv - Cancer Biology 2022Quote: ... in X-VIVO 15 medium (Lonza) for two days at a bead to cells ratio of 3:1 ...
-
bioRxiv - Immunology 2022Quote: ... resuspended in X-vivo media (Lonza) supplemented with 5% human serum (Access Cell Culture ...
-
bioRxiv - Cell Biology 2023Quote: ... resuspended in X-Vivo 15 (Lonza) supplemented with 2 mM Glutamax (Gibco) ...
-
bioRxiv - Neuroscience 2023Quote: ... containing X-Vivo 15 medium (Lonza), 2 mM Glutamax (Gibco) ...
-
bioRxiv - Neuroscience 2023Quote: ... containing X-Vivo 15 medium (Lonza), 2 mM Glutamax (Gibco) ...
-
bioRxiv - Immunology 2024Quote: ... in X-Vivo15 medium (BioWhittaker/Lonza), supplemented with 1000 IU/ml GM-CSF and 400 IU/ml IL-4 (both Miltenyi Biotec ...
-
bioRxiv - Cancer Biology 2020Quote: ... The recombinant plasmid was transfected into HT29 cells using 4D-Nucleofecor (Lonza).
-
bioRxiv - Synthetic Biology 2024Quote: ... using SF Cell line 4D-Nucleofector X Kit L or X Kit S (Lonza, V4XC-2024, V4XC-2032) with the program CQ-104 ...
-
bioRxiv - Developmental Biology 2020Quote: ... and the 4D Nucleofector X Unit (Lonza) following manufacturer’s instructions ...
-
bioRxiv - Molecular Biology 2022Quote: The 4D-Nucleofector System X-Unit (Lonza) was used for nucleofection ...
-
bioRxiv - Genomics 2020Quote: ... in X-VIVO 15 base medium (Lonza). HIM media was changed every 3-4 days for 2-3 weeks until floating CD14-positive myeloid precursors emerged ...
-
bioRxiv - Molecular Biology 2022Quote: ... and with the 4D-Nucleofector X (Lonza) for K562 cells ...
-
bioRxiv - Immunology 2020Quote: ... in X-VIVO 15 (BioWhittaker, Lonza Belgium) medium supplemented with 2% AB human serum (Sigma-Aldrich ...
-
bioRxiv - Immunology 2020Quote: Monocytes were cultured in X-VIVOTM (Lonza) supplemented with 10% autologous serum ...
-
Nonsense Mediated RNA Decay Is a Unique Vulnerability of Cancer Cells with SF3B1 and U2AF1 MutationsbioRxiv - Cell Biology 2021Quote: ... via nucleofection (Lonza, 4D-NucleofectorTM X-unit) using solution P3 (Lonza ...
-
bioRxiv - Genetics 2020Quote: ... The culture cocktail contained X-VIVO10 (Lonza), Albumex (Seqirus ...
-
bioRxiv - Immunology 2021Quote: ... 5% CO2 in X-VIVO 15 (Lonza) supplemented with 5% (v/v ...
-
bioRxiv - Immunology 2022Quote: ... with a 4D Nucleofector X unit (Lonza). After electroporation ...
-
bioRxiv - Molecular Biology 2022Quote: ... The 4D-Nucleofector System X-Unit (Lonza) was used for nucleofection ...
-
bioRxiv - Immunology 2022Quote: ... resuspended in X-VIVO TM 15 (Lonza) and counted on a hemocytometer or using fluorescent count beads on an SH800 Sony Sorter ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 4D-Nucleofector™ X Unit (Lonza). 500,000 cells were pelleted and resuspended in 100µl Nucleofector™ Solution ...
-
bioRxiv - Bioengineering 2023Quote: ... and X-Vivo 20 (Lonza Cat#190995). 3.6uL of a Thrombin mixture ...
-
bioRxiv - Molecular Biology 2023Quote: ... and the 4D-Nucleofector X Unit (Lonza) with pulse code DS-150 ...
-
bioRxiv - Immunology 2023Quote: ... and X-Vivo (Lonza, Cat. BE02-060F) containing 10% FCS (Biochrome ...
-
bioRxiv - Immunology 2024Quote: ... using x-vivo 15 cell medium (Lonza) tissue culture medium supplemented with L-glutamine ...
-
UC2 – A Versatile and Customizable low-cost 3D-printed Optical Open-Standard for microscopic imagingbioRxiv - Bioengineering 2020Quote: ... PBMCs were seeded at a density of 1 x 106cells/cm2 in X-VIVO 15 medium (Lonza, Cologne, Germany) supplemented with 10% (v/v ...
-
bioRxiv - Immunology 2021Quote: ... using SF Cell line 4D-Nucleofector® X Kit L or X Kit S (Lonza, V4XC-2024, V4XC-2032) with the program CQ-104 ...
-
bioRxiv - Cell Biology 2023Quote: ... Viral particles were formulated into either X-VIVO™ 10 or X-VIVO™ 15media (Lonza, Walkersville, MD, USA) or phosphate buffered saline containing 1% human serum albumin (Grifols Biologicals ...
-
bioRxiv - Biophysics 2020Quote: ... hydrocortisone and recombinant human epidermal growth factor (MEGM Bullet Kit CC-4136; Lonza). Cells were maintained in an incubator under standard conditions (36.5 °C ...
-
bioRxiv - Microbiology 2021Quote: ... between 1 x 106 and 1 x 107 cells were resuspended in 18 μl of P3 primary cells solution (Lonza), 2 μl of the restricted cassette (2-4 μg total ...